Search all medical codes

Fibrin(ogen) degradation (split) products (FDP) (FSP); paracoagulation

CPT4 code

Name of the Procedure:

Fibrin(ogen) Degradation (Split) Products (FDP) (FSP); Paracoagulation

  • Common Names: FDP Test, FSP Test
  • Technical Terms: Fibrin Degradation Products, Fibrin(ogen) Split Products

Summary

The FDP test measures the breakdown products of fibrin and fibrinogen in your blood to help diagnose and monitor various clotting disorders.

Purpose

  • Condition Addressed: This test is primarily used to identify clotting disorders such as disseminated intravascular coagulation (DIC), deep vein thrombosis (DVT), and pulmonary embolism.
  • Goals: To detect elevated levels of fibrin degradation products indicating abnormal clot formation and breakdown in the body.

Indications

  • Symptoms or Conditions: Suspicion of clotting disorders, unexplained bleeding, formation of abnormal clots, thrombocytopenia.
  • Patient Criteria: Anyone exhibiting clinical signs of excess clot breakdown, patients undergoing treatment for DIC, or those who had recent surgery or trauma.

Preparation

  • Instructions: Generally, no special preparation like fasting is needed, but follow your healthcare provider’s advice.
  • Pre-procedure Tests: No specific tests required aside from a thorough medical history and physical assessment.

Procedure Description

  1. Blood Sample Collection: A healthcare professional will draw a small amount of blood from your vein, typically from the arm.
  2. Lab Analysis: The blood sample is sent to a laboratory for analysis where specialized assays detect fibrin degradation products.
  3. Tools Used: Standard phlebotomy equipment (needle, syringe, blood vials).

Duration

  • Time Taken: Blood draw takes about 5-10 minutes; lab analysis can take several hours to a day, depending on the facility.

Setting

  • This procedure can be performed in a hospital, outpatient clinic, or diagnostic laboratory.

Personnel

  • Involved Professionals: Phlebotomist, Medical Laboratory Technician, Pathologist.

Risks and Complications

  • Common Risks: Discomfort or bruising at the blood draw site.
  • Rare Risks: Infection, excessive bleeding, fainting.

Benefits

  • Expected Benefits: Provides crucial information on clotting function, aids in diagnosing clotting disorders, and helps guide appropriate treatment.
  • Realization Time: Results are typically available within a day, aiding in rapid diagnosis and management.

Recovery

  • Post-procedure Care: No specific care required post blood draw.
  • Recovery Time: Immediate; normal activities can resume directly after the blood draw.
  • Follow-up: Based on results, additional tests or treatments may be recommended.

Alternatives

  • Other Options: Other clotting factor tests, such as D-dimer tests.
  • Pros and Cons: FDP tests are specific for degradation products, while D-dimer tests are a more general indication of clot breakdown.

Patient Experience

  • During the procedure: Mild discomfort during blood draw.
  • After the procedure: Minor soreness or bruising at the puncture site which typically resolves quickly.
  • Pain Management: Usually not necessary, but ice packs can be used if bruising occurs.

This helps provide a comprehensive overview of what the Fibrin(ogen) Degradation Products test entails and what patients can expect from start to finish.

Similar Codes